| CEO Jeffrey Bacha of DelMar Pharmaceuticals Inc.(NASDAQ: DMPI) returns to Stock Day to discuss finding new drug therapies and current clinical trials.
|
The CEOs interviewed on the Stock Day Podcast did not incur any charges for their time with Uptick Newswire CEO Everett Jolly. Contact us at (602) 441-3474 if you would like further information.
Source: Uptick Newswire
